Cagrilintide Lyophilized Powder 99% Purity for Weight Loss Research - CAS 2381089-83-2

Cagrilintide is an investigational amylin-analog peptide currently being developed for weight management applications. This lyophilized powder formulation offers researchers a stable, high-purity compound for scientific investigation.

As an amylin analog, Cagrilintide demonstrates multiple pharmacological effects that make it particularly interesting for metabolic research. The compound has shown promise in clinical trials for weight management when used in combination with GLP-1 receptor agonists.

The lyophilized powder form ensures excellent stability and convenient reconstitution for research purposes. Our product meets stringent quality control standards with purity exceeding 99%, making it suitable for various research applications.

Key Research Applications:

1. Metabolic syndrome studies

2. Weight management mechanisms

3. Appetite regulation research

4. Combination therapy investigations

5. Pharmacokinetic and pharmacodynamic studies

Mechanism of Action:

Cagrilintide functions as a non-selective agonist designed for subcutaneous administration. Its molecular structure is based on the human amylin backbone with modifications inspired by calcitonin, resulting in a prolonged action profile. The compound appears to exert its effects through both homeostatic and hedonic brain regions, potentially offering synergistic benefits when combined with GLP-1 receptor agonists.

This product is provided for research purposes only. All necessary safety precautions should be followed when handling this material in laboratory settings.